• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于重组生产含短二硫键肽的融合蛋白系统。

A fusion protein system for the recombinant production of short disulfide-containing peptides.

作者信息

Fairlie W Douglas, Uboldi Alessandro D, De Souza David P, Hemmings George J, Nicola Nicos A, Baca Manuel

机构信息

The Walter and Eliza Hall Institute of Medical Research, and The Cooperative Research Centre for Cellular Growth Factors, Post Office, Royal Melbourne Hospital, 3050, Parkville, Vic., Australia.

出版信息

Protein Expr Purif. 2002 Oct;26(1):171-8. doi: 10.1016/s1046-5928(02)00521-1.

DOI:10.1016/s1046-5928(02)00521-1
PMID:12356485
Abstract

A recombinant fusion protein system for the production, oxidation, and purification of short peptides containing a single disulfide bond is described. The peptides are initially expressed in Escherichia coli as a fusion to an engineered mutant of the N-terminal SH2 domain of the intracellular phosphatase, SHP-2. This small protein domain confers several important properties which facilitate the production of disulfide-containing peptides: (i) it is expressed at high levels in E. coli; (ii) it can be purified via a hexahistidine tag and reverse-phase HPLC; (iii) it contains no endogenous cysteine residues, allowing the formation of an intrapeptide disulfide bond while still attached to the fusion partner; (iv) it is highly soluble in native buffers, facilitating the production of very hydrophobic peptides and the direct use of fusion products in biochemical assays; (v) it contains a unique methionine residue at the junction of the peptide and fusion partner to facilitate peptide cleavage by treatment with cyanogen bromide (CNBr). This method is useful for producing peptides, which are otherwise difficult to prepare through traditional chemical synthesis approaches, and this has been demonstrated by preparing a number of hydrophobic disulfide-containing peptides derived from phage-display libraries.

摘要

本文描述了一种用于生产、氧化和纯化含单个二硫键的短肽的重组融合蛋白系统。这些肽最初在大肠杆菌中表达,与细胞内磷酸酶SHP-2的N端SH2结构域的工程突变体融合。这个小蛋白结构域具有几个重要特性,有助于含二硫键肽的生产:(i)它在大肠杆菌中高水平表达;(ii)它可以通过六组氨酸标签和反相高效液相色谱法纯化;(iii)它不含内源性半胱氨酸残基,在仍与融合伴侣相连时允许形成肽内二硫键;(iv)它在天然缓冲液中高度可溶,便于生产非常疏水的肽,并直接在生化分析中使用融合产物;(v)它在肽和融合伴侣的连接处含有一个独特的甲硫氨酸残基,便于用溴化氰(CNBr)处理进行肽切割。该方法对于生产通过传统化学合成方法难以制备的肽很有用,通过制备一些源自噬菌体展示文库的含疏水二硫键的肽已证明了这一点。

相似文献

1
A fusion protein system for the recombinant production of short disulfide-containing peptides.用于重组生产含短二硫键肽的融合蛋白系统。
Protein Expr Purif. 2002 Oct;26(1):171-8. doi: 10.1016/s1046-5928(02)00521-1.
2
Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: purification, oxidation without concatamer formation, and selective cleavage.用于工业生产含二硫键肽的重组融合蛋白:纯化、无串联体形成的氧化及选择性切割
Protein Expr Purif. 1998 Apr;12(3):404-14. doi: 10.1006/prep.1997.0844.
3
A Strategy for Production of Correctly Folded Disulfide-Rich Peptides in the Periplasm of E. coli.一种在大肠杆菌周质中生产正确折叠的富含二硫键肽的策略。
Methods Mol Biol. 2017;1586:155-180. doi: 10.1007/978-1-4939-6887-9_10.
4
Expression of Mastoparan B, a Venom Peptide, Via Escherichia coli C43 (DE3) Coupled with an Artificial Oil Body-Cyanogen Bromide Technology Platform.通过与人工油体-溴化氰技术平台相结合的大肠杆菌C43(DE3)表达毒液肽蜂毒肽B
Protein Pept Lett. 2017;24(11):1021-1029. doi: 10.2174/0929866524666170724161900.
5
Gene design, fusion technology and TEV cleavage conditions influence the purification of oxidized disulphide-rich venom peptides in Escherichia coli.基因设计、融合技术和烟草蚀纹病毒(TEV)切割条件会影响富含二硫键的氧化型毒液肽在大肠杆菌中的纯化。
Microb Cell Fact. 2017 Jan 17;16(1):4. doi: 10.1186/s12934-016-0618-0.
6
Functional expression of bitistatin, a disintegrin with potential use in molecular imaging of thromboembolic disease.比替司他汀的功能表达,一种可用于血栓栓塞性疾病分子成像的整合素。
Protein Expr Purif. 2005 Feb;39(2):307-19. doi: 10.1016/j.pep.2004.11.005.
7
Complex of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein. Disulfide structure and carbohydrate attachment.妊娠相关血浆蛋白-A与嗜酸性粒细胞主要碱性蛋白前体的复合物。二硫键结构与糖基化连接。
J Biol Chem. 2003 Jan 24;278(4):2106-17. doi: 10.1074/jbc.M208777200. Epub 2002 Nov 5.
8
Homodimeric peptides displayed by the major coat protein of filamentous phage.丝状噬菌体主要外壳蛋白展示的同二聚体肽。
J Mol Biol. 2000 Jul 7;300(2):307-20. doi: 10.1006/jmbi.2000.3850.
9
Efficient expression of isotopically labeled peptides for high resolution NMR studies: application to the Cdc42/Rac binding domains of virulent kinases in Candida albicans.用于高分辨率核磁共振研究的同位素标记肽的高效表达:在白色念珠菌中对毒性激酶的Cdc42/Rac结合结构域的应用
J Biomol NMR. 2003 Aug;26(4):317-26. doi: 10.1023/a:1024043620972.
10
Production of recombinant antimicrobial peptides in bacteria.在细菌中生产重组抗菌肽。
Methods Mol Biol. 2010;618:61-76. doi: 10.1007/978-1-60761-594-1_5.

引用本文的文献

1
A novel approach of recombinant laterosporulin production using the N-SH2 domain of SHP-2.利用 SHP-2 的 N-SH2 结构域生产重组 laterosporulin 的新方法。
BMC Biotechnol. 2021 Oct 21;21(1):60. doi: 10.1186/s12896-021-00721-7.
2
Phage-display reveals interaction of lipocalin allergen Can f 1 with a peptide resembling the antigen binding region of a human γδT-cell receptor.噬菌体展示技术揭示了脂联素过敏原 Can f 1 与人 γδT 细胞受体抗原结合区类似的肽的相互作用。
Biol Chem. 2020 Sep 16;402(4):433-437. doi: 10.1515/hsz-2020-0185. Print 2021 Mar 26.
3
A phosphorylation tag for uranyl mediated protein purification and photo assisted tag removal.
用于铀酰介导的蛋白质纯化和光辅助标签去除的磷酸化标签。
PLoS One. 2014 Mar 5;9(3):e91138. doi: 10.1371/journal.pone.0091138. eCollection 2014.
4
Peptide inhibitors of the malaria surface protein, apical membrane antigen 1: identification of key binding residues.疟疾表面蛋白,顶膜抗原 1 的肽抑制剂:关键结合残基的鉴定。
Biopolymers. 2011 May;95(5):354-64. doi: 10.1002/bip.21582. Epub 2011 Jan 6.
5
Making the most of fusion tags technology in structural characterization of membrane proteins.充分利用融合标签技术进行膜蛋白的结构表征。
Mol Biotechnol. 2009 Jun;42(2):135-45. doi: 10.1007/s12033-009-9148-x. Epub 2009 Feb 7.